Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma

References

• Colombo M. Malignant neoplasms of the liver. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff’s disease of the liver. Philadelphia: Lippincott Williams & Wilkins; 2003. pp 1377–403.
   Google Scholar
• Sherlock S, Dooley J. Malignant liver tumors. In: Disease of the liver and biliary system. 11th ed. Oxford: Blackwell Publishing Co; 2002. pp 537–62.
   Google Scholar
• Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi GC, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330–5.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000;32:842–6.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovert JM, Beaugrand M, Lencioni R, Burroughs AK, et al. EASL Panel of Experts on HCC: clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. Eur Assoc Study Liver J Hepatol 2001;35:421–30.
   Google Scholar
• Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Br J Cancer 1995;72:442–6.
   PubMed Web of Science ®Google Scholar
• Tsai JF, Jeng JE, Chuang LY, Yang ML, Ho MS, Chang WY, et al. Clinical evaluation of urinary transforming growth factor-β1 and serum α-fetoprotein as tumor markers of hepatocellular carcinoma. Br J Cancer 1997;75:1460–6.
   PubMed Web of Science ®Google Scholar
• Tsai JF, Chuang LY, Jeng JE, Yang ML, Chang WY, Hsieh MY, et al. Clinical relevance of transforming growth factorbeta 1 in the urine of patients with hepatocellular carcinoma. Medicine 1997;76:213–26.
   PubMed Web of Science ®Google Scholar
• Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, et al. Serum α-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984;86:1404–9.
   PubMed Web of Science ®Google Scholar
• Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986;90:289–98.
   PubMed Web of Science ®Google Scholar
• Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61–6.
   Google Scholar
• Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of realtime ultrasonography. A study in 51 patients. Gastroenterology 1984;86:495–502.
   PubMed Web of Science ®Google Scholar
• Song BC, Chung YH, Kim JA, Choi WB, Suh DD, Pyo SI, et al. Transforming growth factor-beta 1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 2002;94:78–80.
   PubMed Web of Science ®Google Scholar
• LeRoith D, Roberts CT. The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127–37.
   PubMed Web of Science ®Google Scholar
• Fan ZR, Yang DH, Cui J, Qin HR, Huang CC. Expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis. World J Gastroenterol 2001;7:285–8.
   Google Scholar
• Wang Z, Ruan YB, Guan Y, Liu SH. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol 2003;9:267–70.
   PubMed Web of Science ®Google Scholar
• Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, et al. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res 1988;48:6844–9.
   PubMed Web of Science ®Google Scholar
• Song BC, Chung YH, Kim JA, Lee HC, Yoon HK, Sung KB, et al. Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellularcarcinoma: a prospective study. Cancer 2001;91:2386–93.
   PubMed Web of Science ®Google Scholar
• Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer 1997;76:968–74.
   PubMed Web of Science ®Google Scholar
• Tsai JF, Chang WY, Jeng JE, Wang LY, Hsieh MY, Chen SC, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993; 41:296–300.
   PubMed Web of Science ®Google Scholar
• Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994;14:98–102.
   PubMedGoogle Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Peitroni MC, Williams R. Transection of the esophagus for bleeding esohphageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Leroith D, Clemons D, Nissley P, Rechler MM. Insulin-like growth factors in health and disease. Ann Intern Med 1992;116:854–62.
   PubMed Web of Science ®Google Scholar
• Bernstein LH, Leukhardt-Falrfield CJ, Pleban W, Rudolph R. Usefulness of data on albumin and prealbumin concentrations in determining effectiveness of nutritional support. Clin Chem 1989;35:271–4.
   PubMed Web of Science ®Google Scholar
• Sox HC, Blatt MA, Higgins MC, Marton K. Medical decision making. London: Butterworth & Co. Ltd; 1989. pp 67–146
   Google Scholar
• Zweig MH, Campbll G. Receiver-operating chracteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561–77.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–43.
   PubMed Web of Science ®Google Scholar
• Tsai JF, Tsai JH, Chang WY. Relationship of serum α-feto protein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Gastroenterol Jpn 1990;25:388–93.
   Google Scholar
• Tsai JF, Tsai JH, Chang WY, Ton TC. Elevation of circulating immune complexes and its relationship to α-fetoprotein levels in patients with hepatitis B surface antigenpositive hepatocellular carcinoma. Cancer Invest 1991;9:137–43.
   PubMed Web of Science ®Google Scholar
• Chuang LY, Hung WC, Yang ML, Chang CC, Tsai JF. Urinary epidermal growth factor receptor-binding growth factors in patients with cancers of the digestive tract. Clin Biochem 1994;27:485–9.
   Google Scholar
• Edis C, Kahler C, Klotz W, Herold M, Feichtinger H, Konigsreiner A, et al. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma. Transplant Proc 1998;30:780–1.
   PubMed Web of Science ®Google Scholar
• Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A, Fujita N, et al. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology 2002;49:235–8.
   PubMedGoogle Scholar
• Maussier ML, Valenza V, Schinco G, Galli G. AFP, CEA, CA19–9 and TPA in hepatocellular carcinoma. Int J Biol Markers 1990;5:121–6.
   PubMedGoogle Scholar
• Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285–93.
   PubMed Web of Science ®Google Scholar
• Kaneko S, Unoura M, Kobayashi K. Early detection of hepatocellular carcinoma. In: Okud K, Tabor E, editors. Liver cancer. New York: Churchill Livingstone; 1997. pp 393–406.
   Google Scholar
• Scharf JG, Dombrowski F, Ramadori G. The IGF axis and hepatocarcinogenesis. Mol Pathol 2001;54:138–44.
   PubMedGoogle Scholar